Lipid lowering efficacy of atorvastatin

阿托伐他汀 医学 安慰剂 他汀类 荟萃分析 不利影响 胆固醇 内科学 临床试验 血脂 科克伦图书馆 相对风险 随机对照试验 瑞舒伐他汀 置信区间 药理学 替代医学 病理
作者
Stephen P Adams,Michael Tsang,James M Wright
出处
期刊:Cochrane Database of Systematic Reviews [Elsevier BV]
被引量:114
标识
DOI:10.1002/14651858.cd008226.pub2
摘要

Background Atorvastatin is one of the most widely prescribed drugs and the most widely prescribed statin in the world. It is therefore important to know the dose‐related magnitude of effect of atorvastatin on blood lipids. Objectives To quantify the dose‐related effects of atorvastatin on blood lipids and withdrawals due to adverse effects (WDAE). Search methods We searched the Cochrane Central Register of Controlled Trials (CENTRAL) on The Cochrane Library Issue 4, 2011, MEDLINE (1966 to November 2011), EMBASE (1980 to November 2011), ISI Web of Science (1899 to November 2011) and BIOSIS Previews (1969 to November 2011). No language restrictions were applied. Selection criteria Randomised controlled and uncontrolled before‐and‐after trials evaluating the dose response of different fixed doses of atorvastatin on blood lipids over a duration of 3 to 12 weeks. Data collection and analysis Two review authors independently assessed trial quality and extracted data. WDAE information was collected from the placebo‐controlled trials. Main results Two hundred fifty‐four trials evaluated the dose‐related efficacy of atorvastatin in 33,505 participants. Log dose‐response data revealed linear dose‐related effects on blood total cholesterol, low‐density lipoprotein (LDL)‐cholesterol and triglycerides. Combining all the trials using the generic inverse variance fixed‐effect model for doses of 10 to 80 mg/day resulted in decreases of 36% to 53% for LDL‐cholesterol. There was no significant dose‐related effects of atorvastatin on blood high‐density lipoprotein (HDL)‐cholesterol. WDAE were not statistically different between atorvastatin and placebo for these short‐term trials (risk ratio 0.99; 95% confidence interval 0.68 to 1.45). Authors' conclusions Blood total cholesterol, LDL‐cholesterol and triglyceride lowering effect of atorvastatin was dependent on dose. Log dose‐response data was linear over the commonly prescribed dose range. Manufacturer‐recommended atorvastatin doses of 10 to 80 mg/day resulted in 36% to 53% decreases of LDL‐cholesterol. The review did not provide a good estimate of the incidence of harms associated with atorvastatin because of the short duration of the trials and the lack of reporting of adverse effects in 37% of the placebo‐controlled trials.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刘kk发布了新的文献求助10
刚刚
刚刚
秋风的应助被顾北采纳,获得20
刚刚
刚刚
华轩完成签到,获得积分10
1秒前
1秒前
1秒前
2秒前
2秒前
学术纣王发布了新的文献求助10
2秒前
kuangrenluoli完成签到,获得积分10
2秒前
慕青的应助被百事从欢采纳,获得10
2秒前
Akim的应助被神勇从波采纳,获得10
2秒前
我是谁的应助被zzz采纳,获得30
3秒前
斯文败类的应助被刘金磊采纳,获得10
3秒前
尘尘发布了新的文献求助10
3秒前
狂人萝莉完成签到,获得积分10
3秒前
汉堡包的应助被aliye采纳,获得10
4秒前
4秒前
5秒前
5秒前
JustinYoung发布了新的文献求助10
5秒前
zys发布了新的文献求助10
5秒前
lws发布了新的文献求助10
5秒前
SciGPT的应助被兔小小采纳,获得10
6秒前
Akim的应助被王政采纳,获得10
6秒前
6秒前
6秒前
6秒前
6秒前
6秒前
暮离发布了新的文献求助10
6秒前
6秒前
7秒前
暮离发布了新的文献求助10
7秒前
乐乐的应助被小明同学采纳,获得10
7秒前
思源的应助被青青子衿采纳,获得10
7秒前
7秒前
7秒前
暮离发布了新的文献求助10
7秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
What Else Can I Tell You?: A Pragmatic Study of English Rhetorical Questions as Discursive and Argumentative Acts 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8163790
求助须知:如何正确求助?哪些是违规求助? 9557902
关于积分的说明 21742487
捐赠科研通 7754436
什么是DOI,文献DOI怎么找? 3428350
关于科研通互助平台的介绍 2553017
邀请新用户注册赠送积分活动 2472963